The effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. A randomized, double-blind, placebo-controlled study

详细信息    查看全文

• 作者：Alberto P. Madeiro (1) (2)
  Andréa C. Rufino (1) (2)
  Marair G. F. Sartori (3)
  Edmund C. Baracat (3)
  Geraldo Rodrigues De Lima (3)
  Manoel J. B. C. Gir?o (3)
  
• 关键词：Bethanechol ; Cisapride ; Urodynamic study ; Bladder disfunction ; Radical hysterectomy
• 刊名：International Urogynecology Journal
• 出版年：2006
• 出版时间：May 2006
• 年：2006
• 卷：17
• 期：3
• 页码：248-252
• 全文大小：207KB
• 参考文献：1. Larson DM, Malone JM, Copeland LJ, Gershenson DM, Kline RC, Stringer CA (1987) Ureteral assessment after radical hysterectomy. Obstet Gynecol 64: 612-16
  2. Low JA, Mauger GM, Carmichael JA (1981) The effect of Wertheim hysterectomy upon bladder and urethral function. Am J Obstet Gynecol 139:826-34
  3. Carenza L, Nobili F, Giacobini S (1982) Voiding disorders after radical hysterectomy. Gynecol Oncol 13:213-19 CrossRef
  4. Vervest HAM, Barents JW, Haspels AA, Debruyne M (1989) Radical hysterectomy and the function of the lower urinary tract. Acta Obstet Gynecol Scand 68:331-40
  5. Sonda LP, Gershon C, Diokno AC, Lapides J (1979) Further observations on the cystometric and uroflowmetric effects of bethanechol chloride on the human bladder. J Urol 122:775-77
  6. Wein AJ, Malloy TR, Shofer F, Raezer DM (1980) The effects of bethanechol chloride on urodynamic parameters in normal women and in women with significant residual urine volumes. J Urol 124:397-99
  7. Finkbeiner AE (1985) Is bethanechol chloride clinically effective in promoting bladder emptying?. A literature review. J Urol 134:443-49
  8. Carone R, Vercelli D, Bertapelle P (1993) Effects of cisapride on anorectal and vesicourethral function in spinal cord injured patients. Paraplegia 31:125-27
  9. Boyd IW, Rohan AP (1994) Urinary disorders associated with cisapride. Med J Aust 160:579-80
  10. Wyndaele JJ, Kerrebroeck (1995) The effects of 4?weeks treatment with cisapride on cystometric parameters in spinal cord injury patients. A double-blind, placebo controlled study. Paraplegia 33:625-27
  11. Tonini M, Messori E, Franceschetti GP, Rizzi CA, Castoldi AF, Coccini T, Candura SM (1994) Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. Br J Pharmacol 113:1-
  12. Piver MS, Rutledge F, Smith JP (1974) Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44:265-72
  13. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Kerrebroeck PV, Victor A, Wein A (2003) The standardization of terminology in lower urinary tract function: Report from the standardisation sub-committee of the international continence society. Urology 61:37-9 CrossRef
  14. Hirotsu I, Hayano C, Tani T (1998) Effect of muscarinic agonista on overflow incontinence induced by bilateral pelvic nerve transection in rats. Jpn J Pharmacol 76:109-11 CrossRef
  15. Chen GD, Lin, LY, Wang PH, Lee HS (2002) Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecol Oncol 85:292-97 CrossRef
  16. Forney JP (1980) The effect of radical hysterectomy on bladder physiology. Am J Obstet Gynecol 138:374-82
  17. Scotti RJ, Bergman A, Bhatia NN, Ostergard DR (1986) Urodynamic changes in urethrovesical function after radical hysterectomy. Obstet Gynecol 68:111-19
  18. Ralph G, Winter R, Michelistsch L, Tamussino K (1991) Radicality of the parametrial resection and dysfunction of the lower urinary tract after radical hysterectomy. Eur J Gynecol Oncol 12:27-0
  19. Woodside JR, McGuire EJ (1982) Detrusor hypertonicity as a late complication of a Wertheim hysterectomy. J Urol 127:1143-145
  20. Lin HH, Sheu BC, Lo MC, Huang SC (1998) Abnormal urodynamic findings after radical hysterectomy or pelvic irradiation for cervical cancer. Int J Gynecol Obstet 63:169-74 CrossRef
  21. Roman-Lopez JJ, Barclay DL (1972) Bladder dysfunction following Schauta hysterectomy. Am J Obstet Gynecol 115:81-0
  22. Roberts JM, Homesley HD (1978) Observations on bladder function following radical hysterectomy using carbon dioxide cystometry. Surg Gynecol Obstet 147:558-60
  23. Steele AC, Walsh P, Bentley M, Neff J, Karram M (2001) A randomized, double-blind placebo-controlled trial of the effects of the 5-hydroxytriptamine(4) agonist cisapride on the female urinary bladder. Am J Obstet Gynecol 185:62-4 CrossRef
  24. Kemp B, Kitschke HJ, Goetz M, Heyl W (1997) Prophylaxis and treatment of bladder dysfunction after Wertheim-Meigs operation: the positive effect of early postoperative detrusor stimulation using the cholinergic drug betanechol chloride. Int Urogynecol J 8:138-41
  
• 作者单位：Alberto P. Madeiro (1) (2)
  Andréa C. Rufino (1) (2)
  Marair G. F. Sartori (3)
  Edmund C. Baracat (3)
  Geraldo Rodrigues De Lima (3)
  Manoel J. B. C. Gir?o (3)
  
  1. S?o Marcos Hospital, Piauí Cancer Society, Av. Cel. Costa Araújo, 3033, Horto Florestal, Teresina, Piauí, 64049 460, Brazil
  2. Department of Gynecology, Universidade Estadual do Piauí, Brazil
  3. Department of Gynecology, Universidade Federal de S?o Paulo, Brazil
  

文摘

To evaluate the effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. In this double-blind, placebo-controlled study, 79 patients with cervical cancer were randomized to receive bethanechol (30?mg/day), cisapride (30?mg/day), bethanechol combined with cisapride (same doses) and placebo. Urodynamic study was performed, including flowmetry, cystometry, pressure-flow study and urethral pressure profile before radical hysterectomy. Medication was administered postoperatively during 30?days. At the end of this period, urodynamic evaluation was repeated. There was an increase in both the maximum cystometric capacity and bladder capacity at first desire to void in the placebo group compared to the other groups. The rate of detrusor instability was higher in the group that used bethanechol combined with cisapride. Detrusor pressure at maximum flow was significantly higher when cisapride was used. There was a significant increase in postvoid residual volume in the placebo group. In patients undergoing radical hysterectomy, bethanechol and cisapride determined lower cystometric capacity and decreased bladder capacity at first desire to void, a higher maximum flow rate and higher detrusor pressure at maximum flow, with lower postvoid residual volumes. The early use of bethanechol and cisapride after radical hysterectomies positively modified urodynamic parameters, determining a more efficient detrusor function.